HY-15427-10mg
|
MedChemexpress LLC
|
GDC-0834 [CAS 1133432-49-1]
|
|
COVID-19-immunoregulation
|
|
HY-15427-5mg
|
MedChemexpress LLC
|
GDC-0834 [CAS 1133432-49-1]
|
|
COVID-19-immunoregulation
|
|
HY-15427-50mg
|
MedChemexpress LLC
|
GDC-0834 [CAS 1133432-49-1]
|
|
COVID-19-immunoregulation
|
|
HY-15427-1mL
|
MedChemexpress LLC
|
GDC-0834 [CAS 1133432-49-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-115570-1mg
|
MedChemexpress LLC
|
GW406108X [CAS 1644443-92-4]
|
|
COVID-19-immunoregulation
|
|
HY-115570-10mg
|
MedChemexpress LLC
|
GW406108X [CAS 1644443-92-4]
|
|
COVID-19-immunoregulation
|
|
HY-115570-100mg
|
MedChemexpress LLC
|
GW406108X [CAS 1644443-92-4]
|
|
COVID-19-immunoregulation
|
|
HY-115570-25mg
|
MedChemexpress LLC
|
GW406108X [CAS 1644443-92-4]
|
|
COVID-19-immunoregulation
|
|
HY-115570-5mg
|
MedChemexpress LLC
|
GW406108X [CAS 1644443-92-4]
|
|
COVID-19-immunoregulation
|
|
HY-115570-50mg
|
MedChemexpress LLC
|
GW406108X [CAS 1644443-92-4]
|
|
COVID-19-immunoregulation
|
|
HY-115570-1mL
|
MedChemexpress LLC
|
GW406108X [CAS 1644443-92-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-10439-10mg
|
MedChemexpress LLC
|
HPGDS inhibitor 1 [CAS 1033836-12-2]
|
|
COVID-19-immunoregulation
|
|
HY-10439-100mg
|
MedChemexpress LLC
|
HPGDS inhibitor 1 [CAS 1033836-12-2]
|
|
COVID-19-immunoregulation
|
|
HY-10439-5mg
|
MedChemexpress LLC
|
HPGDS inhibitor 1 [CAS 1033836-12-2]
|
|
COVID-19-immunoregulation
|
|
HY-10439-50mg
|
MedChemexpress LLC
|
HPGDS inhibitor 1 [CAS 1033836-12-2]
|
|
COVID-19-immunoregulation
|
|
HY-10439-1mL
|
MedChemexpress LLC
|
HPGDS inhibitor 1 [CAS 1033836-12-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|